Which closed-end funds own Travere Therapeutics Inc?
12 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $47.9M. Security type: debt security. Country: United States. CUSIP 89422GAB3 · ISIN US89422GAB32.
Holdings are historical filings (report dates Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| CHW Calamos Global Dynamic Income Fund | Taxable Bonds | 0.74% | $6.2M | 5,305,000 par | $836M | 9.5% discount | Jul 31, 2026 |
| CGO Calamos Global Total Return Fund | Multi-Asset | 0.74% | $1.5M | 1,245,000 par | $197M | 10.8% discount | Jul 31, 2026 |
| CCD Calamos Dynamic Convertible & Income Fund | Convertible Securities | 0.56% | $5.3M | 4,500,000 par | $939M | 6.7% premium | Jul 31, 2026 |
| CHI Calamos Convertible Opportunities & Income Fund | Convertible Securities | 0.45% | $6.1M | 5,250,000 par | $1.4B | 4.5% premium | Jul 31, 2026 |
| NCZ Virtus Convertible & Income Fund II | Convertible Securities | 0.45% | $2.1M | 1,770,000 par | $463M | 7.6% discount | Jul 31, 2026 |
| CHY Calamos Convertible & High Income Fund | Convertible Securities | 0.44% | $6.4M | 5,500,000 par | $1.5B | 0.3% premium | Jul 31, 2026 |
| NCV Virtus Convertible & Income Fund | Convertible Securities | 0.43% | $2.6M | 2,220,000 par | $601M | 9.6% discount | Jul 31, 2026 |
| ACV Virtus Diversified Income & Convertible Fund | Convertible Securities | 0.40% | $1.5M | 1,320,000 par | $380M | 5.3% discount | Jul 31, 2026 |
| NIE Virtus Equity & Convertible Income Fund | Convertible Securities | 0.26% | $2.1M | 1,765,000 par | $786M | 9.5% discount | Jul 31, 2026 |
| CSQ Calamos Strategic Total Return Fund | Multi-Asset | 0.22% | $10.5M | 9,015,000 par | $4.9B | 9.4% discount | Jul 31, 2026 |
| AVK Advent Convertible & Income Fund | Convertible Securities | 0.20% | $1.5M | 1,321,000 par | $757M | NAV unavailable | Jul 31, 2026 |
| NFJ Virtus Dividend, Interest & Premium Strategy Fund | U.S. Equity | 0.14% | $2.1M | 1,760,000 par | $1.5B | 9.0% discount | Jul 31, 2026 |
12 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Travere Therapeutics Inc | common equity | 2 |
Issuer-level search for “TRAVERE THERAPEUTICS INC” → · Compare two funds’ portfolios →